Cue Biopharma Inc buy Stifel Nicolaus
Start price
09.04.24
/
50%
€1.65
Target price
09.04.25
€7.35
Performance (%)
-61.70%
End price
10.04.25
€0.63
Summary
This prediction ended on 10.04.25 with a price of €0.63. The BUY prediction by Stifel_Nicolaus for Cue Biopharma Inc performed very badly with a performance of -61.70%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | 37.255% | 37.255% | -4.502% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten